Drug class in one race
IL-6R antagonist drugs for Rheumatoid Arthritis
2 tracked IL-6R antagonist drugs in the Rheumatoid Arthritis race. The class explanation lives on the IL-6R antagonist page; the full indication pipeline across every mechanism is on the Rheumatoid Arthritis page.
2 approved / phase 4
Head-to-head evidence: CT-P47 (tocilizumab) vs tocilizumab